PREVALENCE OF POLYMORPHISM OF THE TLR 9 TYPE GENE IN PATIENTS WITH CHRONIC FORMS OF INFECTIOUS MONONUCLEOSIS

Authors

  • T. I. Liadova V. N. Karazin Kharkiv National University, Kharkiv, Ukraine

DOI:

https://doi.org/10.11603/1681-2727.2018.1.8670

Keywords:

chronic Epstein-Barr virus, Toll-like receptors, polymorphism, prevalence.

Abstract

The aim of the study. To determine the TLR-914 T/C gene polymorphism in patients with CVEB caused by Epstein-Barr virus.

Materials and methods. Research for the determination of polymorphism -1486 T/C TLR-9 gene was performed in 44 patients with chronic forms of the VEB infection. A control group to study the prevalence of polymorphism -1486 T/C TLR-9 gene were 40 healthy donors. For detecting the DNA of the VEB by PCR with reverse transcription with hybridization and fluorescence detection of amplification products, the Amplisents reagent sets (Russia) were used. DNA isolation from the specimens was performed using a kit for DNA extraction by the Miniprep Company (Siles M, Russia), using the sorption assay technique of the sorbent. Polymorphic region -1486 T/C, rs187084 of the TLR9 gene was studied by real-time PCR amplification by determining the length of the restriction fragment-PCR using restriction enzymes Ncol and oligonucleotide primers.

Results. The analysis of the results of the -1486 T/C polymorphism of the TLR-9 gene revealed three main genotypes – TT, TC, CC. Investigation of the frequency of occurrence of individual genotypes revealed the dominance of the genotype TC, compared with the homozygous genotypes of TT and CC. The study of frequency distribution of the TLR -1486 T/C gene polymorphism for different genotypes demonstrated the specificity of changes in the TC genotype in patients with HEBV and the absence of such for the genotypes of TT and CC.

 

References

Drutskaya, M.S., Belousov, P.V., & Nedospasov, S.A. (2011). Vrozhdennoye raspoznavaniye virusov [Congenital virus detection]. Molekulyarnaya biologiya, 25(3), 7-19 [in Russian].

Barton, G.M. (2007). Viral recognition by Toll-like receptors. Seminars in Immunology, 19(1), 33-40.

Kawai, T., & Akira, S. (2010). The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nature Immunology, 11(5), 373-384.

Torres, S., Hernández, J.C., Giraldo, D., Arboleda, M., Rojas, M., Smit, J.M., & Urcuqui-Inchima, S. (2013). Differential expression of Toll-like receptors in dendritic cells of patients with dengue during early and late acute phases of the disease. PLoS Neglected Tropical Diseases, 7 (2), e2060.

Gibson, J., Gow, N., & Wong, S.Y.C. (2010). Expression and functions of innate pattern recognition receptors in T and B cells. Immunology‚ Endocrine & Metabolic Agents in Medicinal Chemistry, 10(1), 11-20.

Iskra, S., Kalla, M., Delecluse, H.-J., Hammerschmidt, W., & Moosmann, A. (2010). Toll-like receptor agonists synergistically increase proliferation and activation of B cells by Epstein-Barr virus. Journal of Virology, 84 (7), 3612-3623.

Bochud, P.-Y., Hersberger, M., Taffé, P., Bochud, M., Stein, C. M., Rodrigues, S. D., … Aderem, A. (2007). Polymorphisms in Toll-like receptor 9 influence the clinical course of HIV-1 infection. AIDS, 21 (4), 441-446.

Thuong, N.T., Hawn, T.R., Thwaites, G.E., Chau, T.T. H., Lan, N.T., Quy, H.T., … & Dunstan, S.J. (2007). A polymorphism in human TLR2 is associated with increased susceptibility to tuberculous meningitis. Genes and Immunity, 8 (5), 422-428.

Carvalho, A., Cunha, C., Almeida, A.J., Osório, N.S., Saraiva, M., Teixeira-Coelho, M., … & Rodrigues, F. (2011). The rs5743836 polymorphism in TLR9 confers a population-based increased risk of non-Hodgkin lymphoma. Genes and Immunity, 13 (2), 197-201.

Kijpittayarit, S., Eid, A.J., Brown, R.A., Paya, C.V., & Razonable, R.R. (2007). Relationship between Toll-like receptor 2 polymorphism and cytomegalovirus disease after liver transplantation. Clin. Infect. Dis., 44 (10), 1315-1320.

Gaudreault, E., Fiola, S., Olivier, M., & Gosselin, J. (2007). Epstein-Barr virus induces MCP-1 secretion by human monocytes via TLR2. J. Virology, 81(15), 8016-8024.

Fathallah, I., Parroche, P., Gruffat, H., Zannetti, C., Jo­hans­son, H., Yue, H., … Hasan, U.A. (2010). EBV latent membrane protein 1 is a negative regulator of TLR9. J. Immunology, 185(11), 6439-6447.

Paradowska, E., Jabłońska, A., Studzińska, M., & Skowrońs­ka, K. (2016). TLR9 -1486T/C and 2848C/T SNPs are associated with human cytomegalovirus infection in infants. PLOS ONE, 11(4), e0154100.

Fiola, S., Gosselin, D., Takada, K., & Gosselin, J. (2010). TLR9 contributes to the recognition of EBV by primary monocytes and plasmacytoid dendritic cells. J. Immunology, 185(6), 3620-3631.

Published

2018-03-07

How to Cite

Liadova, T. I. (2018). PREVALENCE OF POLYMORPHISM OF THE TLR 9 TYPE GENE IN PATIENTS WITH CHRONIC FORMS OF INFECTIOUS MONONUCLEOSIS. Infectious Diseases – Infektsiyni Khvoroby, (1), 33–39. https://doi.org/10.11603/1681-2727.2018.1.8670

Issue

Section

Original investigations